Quercetin and metabolic syndrome: A review

A Hosseini, BM Razavi, M Banach… - Phytotherapy …, 2021 - Wiley Online Library
Metabolic syndrome (MetS) is a complex of diseases that lead to mortality due to the
development of cardiovascular problems. Quercetin, as an important flavonoid, has various …

2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of …

N Galiè, M Humbert, JL Vachiery, S Gibbs… - European heart …, 2016 - academic.oup.com
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and can complicate the majority of cardiovascular and respiratory …

[PDF][PDF] 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

N Galiè, M Humbert, JL Vachiery… - Polish Heart …, 2015 - journals.viamedica.pl
6.2. 2. Wydolność wysiłkowa......................... 1147 6.2. 3. Markery biochemiczne........................
1147 6.2. 4. Kompleksowa ocena rokownicza i oszacowanie ryzyka........................... 1148 6.2 …

The registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult lung and heart-lung transplantation report—2017; focus theme: allograft …

DC Chambers, RD Yusen, WS Cherikh… - The Journal of Heart …, 2017 - jhltonline.org
This 34th Adult Lung and Heart-Lung Transplant Report summarizes data from 60,107 adult
lung and 3,992 adult heart-lung transplants performed through June 30, 2016, and reported …

Pediatric pulmonary hypertension: guidelines from the American heart association and American thoracic society

SH Abman, G Hansmann, SL Archer, DD Ivy, I Adatia… - Circulation, 2015 - Am Heart Assoc
Pulmonary hypertension is associated with diverse cardiac, pulmonary, and systemic
diseases in neonates, infants, and older children and contributes to significant morbidity and …

Updated clinical classification of pulmonary hypertension

G Simonneau, MA Gatzoulis, I Adatia… - Journal of the American …, 2013 - jacc.org
In 1998, a clinical classification of pulmonary hypertension (PH) was established,
categorizing PH into groups which share similar pathological and hemodynamic …

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension

HA Ghofrani, AM D'Armini, F Grimminger… - … England Journal of …, 2013 - Mass Medical Soc
Background Riociguat, a member of a new class of compounds (soluble guanylate cyclase
stimulators), has been shown in previous clinical studies to be beneficial in the treatment of …

[HTML][HTML] Haemodynamic definitions and updated clinical classification of pulmonary hypertension

G Simonneau, D Montani… - European respiratory …, 2019 - Eur Respiratory Soc
Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary
hypertension (PH) has been arbitrarily defined as mean pulmonary arterial pressure …

Endothelial-to-mesenchymal transition in pulmonary hypertension

B Ranchoux, F Antigny, C Rucker-Martin, A Hautefort… - Circulation, 2015 - Am Heart Assoc
Background—The vascular remodeling responsible for pulmonary arterial hypertension
(PAH) involves predominantly the accumulation of α-smooth muscle actin–expressing …

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

JG Coghlan, CP Denton, E Grünig… - Annals of the …, 2014 - ard.bmj.com
Objective Earlier detection of pulmonary arterial hypertension (PAH), a leading cause of
death in systemic sclerosis (SSc), facilitates earlier treatment. The objective of this study was …